Identification of risk factors for post-induction hypotension in patients receiving 5-aminolevulinic acid: a single-center retrospective study.
5-Aminolevulinic acid
Anesthesia
Hypotension
Journal
JA clinical reports
ISSN: 2363-9024
Titre abrégé: JA Clin Rep
Pays: Germany
ID NLM: 101682121
Informations de publication
Date de publication:
12 May 2020
12 May 2020
Historique:
received:
02
03
2020
accepted:
30
04
2020
entrez:
14
5
2020
pubmed:
14
5
2020
medline:
14
5
2020
Statut:
epublish
Résumé
5-Aminolevulinic acid (5-ALA) is useful as a photodynamic agent, but its use commonly leads to hypotension. Although avoiding a mean arterial pressure (MAP) < 60 mmHg is important, the incidence of MAP < 60 mmHg when using 5-ALA is unclear. Therefore, we conducted a retrospective study to assess the incidence of post-induction hypotension and identified risk factors of this phenomenon. One-hundred and seventy-two consecutive patients who underwent transurethral resection of the bladder tumor or craniotomy with the use of 5-ALA were enrolled. The primary outcome was the incidence of post-induction hypotension, defined as MAP < 60 mmHg during the first 1 h after anesthesia induction. We divided participants into the normal blood pressure group (group N) and the hypotension group (group L). The incidence of post-induction hypotension was 70% (group L = 121, group N = 51). Multivariate analysis revealed that female sex was an independent factor of post-induction hypotension (odds ratio [OR] 3.95; 95% confidence interval [CI] 1.21-12.97; p = 0.02). Systolic blood pressure < 100 mmHg before anesthesia induction and general anesthesia were also identified as significant independent factors (OR 13.30; 95% CI 1.17-151.0; p = 0.04 and OR 25.84; 95% CI 9.80-68.49; p < 0.001, respectively). The incidence of post-induction hypotension was 70% in patients using 5-ALA. Female sex, systolic blood pressure < 100 mmHg before anesthesia induction, and general anesthesia might be independent factors of post-induction hypotension when using 5-ALA.
Sections du résumé
BACKGROUND
BACKGROUND
5-Aminolevulinic acid (5-ALA) is useful as a photodynamic agent, but its use commonly leads to hypotension. Although avoiding a mean arterial pressure (MAP) < 60 mmHg is important, the incidence of MAP < 60 mmHg when using 5-ALA is unclear. Therefore, we conducted a retrospective study to assess the incidence of post-induction hypotension and identified risk factors of this phenomenon.
METHODS
METHODS
One-hundred and seventy-two consecutive patients who underwent transurethral resection of the bladder tumor or craniotomy with the use of 5-ALA were enrolled. The primary outcome was the incidence of post-induction hypotension, defined as MAP < 60 mmHg during the first 1 h after anesthesia induction. We divided participants into the normal blood pressure group (group N) and the hypotension group (group L).
RESULTS
RESULTS
The incidence of post-induction hypotension was 70% (group L = 121, group N = 51). Multivariate analysis revealed that female sex was an independent factor of post-induction hypotension (odds ratio [OR] 3.95; 95% confidence interval [CI] 1.21-12.97; p = 0.02). Systolic blood pressure < 100 mmHg before anesthesia induction and general anesthesia were also identified as significant independent factors (OR 13.30; 95% CI 1.17-151.0; p = 0.04 and OR 25.84; 95% CI 9.80-68.49; p < 0.001, respectively).
CONCLUSIONS
CONCLUSIONS
The incidence of post-induction hypotension was 70% in patients using 5-ALA. Female sex, systolic blood pressure < 100 mmHg before anesthesia induction, and general anesthesia might be independent factors of post-induction hypotension when using 5-ALA.
Identifiants
pubmed: 32399904
doi: 10.1186/s40981-020-00340-9
pii: 10.1186/s40981-020-00340-9
pmc: PMC7218031
doi:
Types de publication
Journal Article
Langues
eng
Pagination
35Références
JA Clin Rep. 2019 Sep 4;5(1):58
pubmed: 32025993
J Pharmacol Exp Ther. 2016 Feb;356(2):267-75
pubmed: 26588930
Arab J Urol. 2017 Mar 06;15(2):100-109
pubmed: 29071138
Front Oncol. 2019 Jul 17;9:620
pubmed: 31380272
Acta Anaesthesiol Scand. 2003 Mar;47(3):241-59
pubmed: 12648189
Br J Anaesth. 2019 May;122(5):563-574
pubmed: 30916004
Int J Urol. 2019 Nov;26(11):1064-1068
pubmed: 31512303
Photodiagnosis Photodyn Ther. 2013 Dec;10(4):362-7
pubmed: 24284086
Med Mol Morphol. 2018 Dec;51(4):187-193
pubmed: 29619546
Am J Physiol Lung Cell Mol Physiol. 2006 Sep;291(3):L337-44
pubmed: 16899710
Photodiagnosis Photodyn Ther. 2013 Feb;10(1):39-41
pubmed: 23465371
J Urol. 2017 Mar;197(3 Pt 1):548-558
pubmed: 27780784